Browse By: Country ι Category ι Latest Reports ι Tag

Global Cardiac Bio Implant Devices (Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Heart Valve, Coronary Stent, Peripheral Stent, Ventricular Assist Device) Market Forecast, Clinical Trials, M&A

Pages » 284
Published By » Renub Research
Price » $1600
In stock
View Report Details
Description

The cardiac implant medical device market is forecasted to grow in single digit percent per year during 2010-2017 and is likely to exceed US$ 27 Billion by 2017. Growth in this sector is anticipated to grow despite continuing product recalls and safety controversies, particularly in the Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers segment. Product innovation, together with demographic structure of the world population, will play a pivotal role in the future growth of the market. Additionally, developing healthcare sector and advanced infrastructure along with infusion of new professional skills and expertise in emerging economies continue to propel long-term grow... Click here for more details


Manufacturing of Biologics - Increasing Demand for Monoclonal Antibodies and Recombinant Proteins Drives Increases in Capacities and Innovative Production Technologies
GBI Research\'s report, “Manufacturing of Biologics - Increasing Demand for Monoclonal Antibodies and Recombinant Proteins Drives Increases in Capacities and Innovative Production Technologies”, provides the key data and analyzes the major challenges and drivers for the biomanufact
Published Date: Sep 2010
Price: $3500
Biomarkers in Cancer Research - High Unmet Need in Cervical Cancer and Lung Cancer to Drive Growth
GBI Research, the leading business intelligence provider, has released its latest report, “Biomarkers in Cancer Research - High Unmet Need in Cervical Cancer and Lung Cancer to Drive Growth” that provides key data, information and analysis of the major trends and issues affecti
Published Date: Sep 2010
Price: $3500
Nanotechnology in Drug Delivery - Technological Improvements and Novel Approaches to Fulfill High Potential
GBI Research, the leading business intelligence provider, has released its latest report, “Nanotechnology in Drug Delivery - Technological Improvements and Novel Approaches to Fulfill High Potential” that provides key data, information and analysis of the major trends and issues in
Published Date: Dec 2010
Price: $3500
Biotechnology Industry 2010 Yearbook - Top Biologics, Biosimilars, Licensing and Financing, Mergers and Acquisitions
GBI Research, the leading business intelligence provider, has released its latest report, “Biotechnology Industry 2010 Yearbook - Top Biologics, Biosimilars, Licensing and Financing, Mergers and Acquisitions” that provides key data, information and analysis of the major trends and
Published Date: Dec 2010
Price: $3500
Early Stage Drug Discovery in Disease Segments - Innovation Focuses on Stem Cell Therapies and Gene Therapies
GBI Researchs new report, Early Stage Drug Development in Disease Segments Innovation Focuses on Stem Cell Therapies and Gene Therapies, provides an in-depth analysis of the unmet needs, drivers and barriers that affect the global Central Nervous System Disorders (CNS), Metabolic Disorders, Immu
Published Date: Feb 2011
Price: $3500
Biobanks - 2011 Yearbook
GBI Research, the leading business intelligence provider, has released its latest research, Biobanks - 2011 Yearbook. It provides key data, information and analysis of the 40 major biobanks in the world. The report provides information on the population-based biobanks, disease based biobanks, brai
Published Date: Mar 2011
Price: $3500
Clinical Trial Endpoints in Oncology - Inclusion of Surrogate Endpoints and Shorter Endpoints Will Ensure Faster Clinical Trials in Oncology
GBI Research, the leading business intelligence provider, has released its latest research Clinical Trial Endpoints in Oncology Inclusion of Surrogate Endpoints and Shorter Endpoints will Ensure Faster Clinical Trials in Oncology, which essentially provides insights into clinical trial endpoints i
Published Date: Mar 2011
Price: $3500
Biosimilars Approval Pathways in the US and Europe - Development and Approval of Biosimilar mABs May Face Tough Regulatory Environment
GBI Research, the leading business intelligence provider, has released its latest report, Biosimilars Approval Pathways in the US and Europe Development and Approval of Biosimilar mAbs May Face Tough Regulatory Environment that provides key data, information and analysis of the major trends and is
Published Date: Apr 2011
Price: $3500
Cancer Supportive Care Products Market to 2016 - Market is Expected to Decline after 2014 Due to Generic Erosion and Entry of Biosimilars
GBI Research, the leading business intelligence provider, has released its latest research, Cancer Supportive Care Products Market to 2016 Market is Expected to Decline after 2014 Due to Generic Erosion and Entry of Biosimilars, which provides insights into the cancer supportive care products mark
Published Date: Apr 2011
Price: $3500
Orthobiologics Market to 2016 - Alternatives to Surgery and Superior Outcomes are Driving Wider Adoption of Orthobiologics
GBI Researchs new report, Orthobiologics Market to 2016 - Alternatives to Surgery and Superior Outcomes are Driving Wider Adoption of Orthobiologics provides key data, information and analysis on the Orthobiologics industry and analytical content on the market dynamics. The report provides mar
Published Date: Jun 2011
Price: $3500

 


 

Related News

Germany Decides Not to Rely on Google to Test Autonomous Cars
The government in Germany has expressed its desire to convert a portion of the A9 Autobahn in Bavaria into what could be a testing field for advanced and innovative car technologies. According to the transport minister of Germany, this project will ensure that the country maintains its ‘digital sovereignty’.  The project is called Digitales Testfeld Autobahn and the track will most probably be launched anytime this year. The plan is to equip all the roads on the track with pr
Date: Jan 27

Auto Industry Boosts Profit for Texas Instruments
The last quarter of 2014 went exceptionally well for Texas Instruments Inc. The company closed with high revenue figures in the fourth quarter of 2014 on Monday and is expecting similar returns for the ongoing quarter as well. This steady increase in its revenue generation can be attributed to the growing demand for chips in the auto industry. The company revealed its revenue figures for the last quarter on Monday that shows a turnover of $3.27 billion. Its revenue figures have risen by 8% compa
Date: Jan 27

Apple Joins Hand with Distribution Giant Brightstar to Boost Sales in India
The maker of iPad and iPhones, Apple, has decided to collaborate with global retail giant Brightstar to boost sales for its devices in India. Apple has set an ambitious target for itself to capitalize on market opportunities in India. The electronic major is looking forward to increase sales from 1 million units that it achieved in the fiscal year ending of 2014, to 7 million units by the end of 2018.  Brightstar, the US-headquartered company is controlled by Softbank, the Japanese telec
Date: Jan 27

Brazil’s Oi to Pocket $6.7 billion Gain from PT Portugal Sale
Oi SA, the leading telecommunications company in Brazil is eyeing to book a net profit of $6.7 billion from the sale of its operating unit PT Portugal to Altice SA. According to sources, the proceeds from the sale will be used by the company to clear off its existing debts. Oi is looking forward to merge with PT Portugal’s parent company, Portugal Telecom SGPS SA. After weeks of discussion, the shareholders of Portugal Telecom finally approved the sale of its operating unit to the Luxembou
Date: Jan 27

Utah Placed Second in Toxic Chemical Releases: EPA
Utah has one of the biggest open-pit copper mines in the world. It deals with a particularly large volume of lead compounds. A recent annual record by the EPA states that Utah ranks at second place out of fifty six states and territories across the country for total toxic releases every square mile. Alaska was ranked first. In 2013, the toxic release inventory by EPA stated that Utah held nearly 12.7% of the total of such releases across the nation, having the majority of which comes from the
Date: Jan 27

US and Brazil to drive growth of bio-based materials market
Driven by growth in Brazil and the U.S., the capacity to manufacture bio-based chemicals and materials from advancing technologies, worldwide, will rise to around 7.4 million metric tons in 2018, which is more than three times from 2008 levels, as stated by Lux Research.   According to Mr. Andrew Soare, senior analyst of Lux Research, high growth is expected in North America, having 17 bio-based chemicals and materials facilities set to come online, many led by developing technology such
Date: Jan 27

Online Car Purchase Portal to be Started by AutoNation
According to Mike Jackson, the CEO of AutoNation Inc., the company will soon be applying its AutoNation Express principle to online car purchasing to Florida during the next quarter. This business expansion has taken place after the launch of AutoNation Express in December the year earlier in South of Florida.  Prior to that launch, AutoNation had altered the name from the SmartChoice Express moniker that was used by it AutoNation described this approach as its digital storefront, which
Date: Jan 23

Ford Establishes a Research and Innovation Unit in Palo Alto
The Ford Motor Company will soon be establishing an expanded Research and Innovation Center in Palo Alto. The company has plans of employing 125 people in the new building and its focus will essentially be on future technology in the areas of human-machine interface, autonomous driving, big data, car connectivity, and smart mobility. Few of the center’s employees are expected to come from Ford’s headquarters in Michigan, however, a major part of the team will be new recruits who will
Date: Jan 23

Shareholders at Portugal Telecom Holders Approve Deal with Altice
Shareholders at Portugal Telecom SGPS SA sanctioned sale of Luxembourg-based Altice SA at a price of US$8.6 billion. This finally spells a definition for the deal that was in process for a long time. The acquisition will make Altice an important competitor in Portugal, to stand next in line with NOS and Vodafone Group PLC.  At present Altice also has operations in Israel and Belgium. Patrick Drahi, the owner is firm on his stand that he intends to expand the company’s markets in th
Date: Jan 23

Vodafone India’s Managing Director Marten Pieters to Retire in April 2015
Vodafone Managing Director, India, Pieters will be retiring from his position on April 1, 2015. During his reign he took the government at every turn right from regulatory issues, tax, or auction of spectrum. He has been the longest running managing director in the history of Indian telecom industry from February 2009. The current chief operating officer, Sunil Sood will take over from Pieters to head the company. Pieters was fondly nicknamed “Crusader” Pieters was the unflinching
Date: Jan 23

Upcoming Reports

Hormone Replacement Therapy Market - Global Industry Size, Market Share, Trends, Analysis And Forecasts, 2012 - 2018
Hormone replacement therapy (HRT) is administration of hormones to those patients who are under a phase of declining natural hormones in their body. Hormone replacement therapy is mostly administered to women undergoing menopausal phase. The hormones which are administered to patients are most
Published By: Transparency Market Research
Price: $4795
Bio-Implants Market - Global Industry Analysis, Market Size, Market Share And Forecast, 2012 - 2018
Bio-implants are bioengineered products known to be of human or animal origin used in the different fields of ENT. Generally, these bio-implants are offered for safeguarding after tissue replacement. These bio-implants are made up of biosynthetic materials known as collagen or it can also be made
Published By: Transparency Market Research
Price: $4795
Biobanks Market - Global Industry Size, Market Share, Trends, Analysis And Forecast, 2012 - 2018
Biobanks is a collection or storation of blood and cell samples from a large number of people. Biobank collection denotes its use in medical field and research. The global biobank industry is segmented into different sectors such as human tissue banking, or population banking, stem cell banking, c
Published By: Transparency Market Research
Price: $4795
Orthobiological Products Market - Global Industry Analysis, Market Size, Market Share And Forecasts, 2012 - 2018
The global orthobiological products market is expected to grow to $15.3 billion by the year 2022 as a result of tremendous growth in the medical devices industry mainly due to increase in aging population. Growth of orthobiological products is driven by increasing awareness towards adoption of ort
Published By: Transparency Market Research
Price: $4795
Gene Amplification Technologies Market - Global Industry Analysis, Market Size, Market Share And Forecasts, 2012 - 2018
Gene amplification technology is proving to be an important technology in human genome projects and other important fields like diagnostics. There are number of companies involved in the business of gene amplification and diagnostics with over 30 gene and signal amplification technologies. These g
Published By: Transparency Market Research
Price: $4795
DNA Sequencing Market - Global Industry Analysis, Market Size, Market Share And Forecasts, 2012 - 2018
The global DNA sequencing market is forecast to grow to $6.6 billion over the year 2016 at the compounded annual growth rate of 17.5% as a result of emerging technologies in this field and its use in a number of applications.   DNA sequencing industry is segmented into instruments and consu
Published By: Transparency Market Research
Price: $4795
Epigenetics Market - Global Industry Analysis, Market Size, Market Share And Forecasts, 2012 - 2018
The global epigenetics market is projected to reach the value of $18.2 billion by the year 2015 driven by investigation of factors influencing cellular malfunction and disease development. Also, developments in epigenetic studies like biomarker discovery and scientifically useful biomarker tests a
Published By: Transparency Market Research
Price: $4795
Biologics Market - G7 Industry Size, Market Share, Trends, Analysis, And Forecasts 2012 - 2018
With an increase in the number of clinical trials in the past 5 years, the market for biologics is expected to witness a high growth during the coming years. Monoclonal antibodies, vaccines and therapeutic proteins will contribute significantly to the growth in the biologics market. The global
Published By: Transparency Market Research
Price: $4795
Biosimilar and Follow-On Biologics Market - Global Industry Size, Market Share, Trends, Analysis And Forecasts 2012 - 2018
There is a rising demand for low cost biological drugs. Commercial and regulatory developments are taking the follow-on biologics market to new heights. Drug manufacturers are exploring the possibilities of producing generic biopharmaceuticals drugs with a motive of reducing the prices of thes
Published By: Transparency Market Research
Price: $4795
Biopesticides Market - Global Industry Analysis, Market Size, Market Share And Forecasts, 2012 - 2018
Biopesticides are essential for controlling the effect of agricultural pests, insects, and bacterial and fungal growth on food and field crops. Use of biopesticides can avoid the hazards caused by the use of chemical pesticides on the environment. Growing environmental concerns and stringent r
Published By: Transparency Market Research
Price: $4795